Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 6/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 5/20 | 1.00 |
| ▸ | SNCA | P37840 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | APEX1 | P27695 | 4/20 | 1.00 |
| ▸ | RECQL | P46063 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | RAD52 | P43351 | 2/20 | 1.00 |
| ▸ | CNR1 | P21554 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 4/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.74 |
| ▸ | GAA | P10253 | 3/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.74 |
| ▸ | PKM | P14618 | 2/20 | 0.74 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Epigallocatechin SCHEMBL29870730 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| (-)-Gallocatechin SCHEMBL30159803 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| Epigallocatechin SCHEMBL20203645 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| Epigallocatechin SCHEMBL12840936 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| Epigallocatechin SCHEMBL1972940 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| Epigallocatechin SCHEMBL12285364 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| Epigallocatechin SCHEMBL19553 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| (-)-Gallocatechin SCHEMBL1742127 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| Gallocatechin SCHEMBL3872234 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| Epigallocatechin SCHEMBL29929503 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117942405-A | Compositions and methods for protecting airborne pathogens and irritants | 应用生物实验室公司 | 2024-04-30 | — | — | CN | claimed |
| CN-114391574-B | Color-protecting antioxidant for stabilized tea Huang Surou product and preparation method thereof | 中华全国供销合作总社杭州茶叶研究所 | 2024-06-14 | — | — | CN | disclosed |
| CN-117942405-A | Compositions and methods for protecting airborne pathogens and irritants | 应用生物实验室公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-115348821-A | Novel nutrient for enhancing load-induced muscle hypertrophy | 加利福尼亚大学董事会 | 2022-11-15 | — | — | CN | disclosed |
| CN-115068465-A | Application of gallocatechin-7-gallate in anti-coronavirus drugs | 中国医学科学院药物研究所 | 2022-09-20 | — | — | CN | disclosed |
| CN-114391574-A | Stable theaflavin meat product color-protecting antioxidant and preparation method thereof | 中华全国供销合作总社杭州茶叶研究所 | 2022-04-26 | — | — | CN | disclosed |
| US-20180243260-A1 | METHODS OF TREATING COGNITIVE AND BEHAVIORAL IMPAIRMENT IN DOWN SYNDROME AND ALZHEIMERS DISEASE PATIENTS | AVANTI BIOSCIENCES, INC. | 2018-08-30 | — | — | US | disclosed |
| US-20180000774-A1 | METHODS OF TREATING COGNITIVE AND BEHAVIORAL IMPAIRMENT IN DOWN SYNDROME AND ALZHEIMERS DISEASE PATIENTS | AVANTI BIOSCIENCES, INC (US) | 2018-01-04 | — | — | US | disclosed |
| US-20170355932-A1 | CLEANING COMPOSITIONS INCLUDING NUCLEASE ENZYME AND TANNINS | THE PROCTER & GAMBLE COMPANY | 2017-12-14 | — | — | US | disclosed |
| US-20170355932-A1 | CLEANING COMPOSITIONS INCLUDING NUCLEASE ENZYME AND TANNINS | THE PROCTER & GAMBLE COMPANY | 2017-12-14 | — | — | US | disclosed |
| EP-2637649-A2 | COMPOUNDS AND METHODS FOR TREATING PAIN | Akron Molecules GmbH (AT) | 2013-09-18 | — | — | EP | disclosed |
| WO-2012062925-A2 | COMPOUNDS AND METHODS FOR TREATING PAIN | AKRON MOLECULES GMBH (AT) | 2012-05-18 | — | — | WO | disclosed |
| US-20110144125-A1 | Anti-Arrhythmia Agents, Methods of Their Use, Methods of Their Identification and Kits Therefore | THE UAB RESEARCH FOUNDATION (US) | 2011-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180243260-A1 | METHODS OF TREATING COGNITIVE AND BEHAVIORAL IMPAIRMENT IN DOWN SYNDROME AND ALZHEIMERS DISEASE PATIENTS | CHAT, CAMK2A, CAMK1G | BACE1 143/4885KDM4E 2235/4885PTGS1 2196/4885 |
| US-20180000774-A1 | METHODS OF TREATING COGNITIVE AND BEHAVIORAL IMPAIRMENT IN DOWN SYNDROME AND ALZHEIMERS DISEASE PATIENTS | CHAT, CAMK2A, CAMK1G | BACE1 132/4885KDM4E 1759/4885PTGS1 2239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.